57 related articles for article (PubMed ID: 6269488)
1. Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.
Okonogi K; Kuno M; Kida M; Mitsuhashi S
Antimicrob Agents Chemother; 1981 Aug; 20(2):171-5. PubMed ID: 6269488
[TBL] [Abstract][Full Text] [Related]
2. Copper Influences the Antibacterial Outcomes of a β-Lactamase-Activated Prochelator against Drug-Resistant Bacteria.
Zaengle-Barone JM; Jackson AC; Besse DM; Becken B; Arshad M; Seed PC; Franz KJ
ACS Infect Dis; 2018 Jun; 4(6):1019-1029. PubMed ID: 29557647
[TBL] [Abstract][Full Text] [Related]
3. Antisense Oligonucleotide Activation via Enzymatic Antibiotic Resistance Mechanism.
Darrah KE; Albright S; Kumbhare R; Tsang M; Chen JK; Deiters A
ACS Chem Biol; 2023 Oct; 18(10):2176-2182. PubMed ID: 37326511
[TBL] [Abstract][Full Text] [Related]
4. Vinyl azides in organic synthesis: an overview.
Gholami F; Yousefnejad F; Larijani B; Mahdavi M
RSC Adv; 2023 Jan; 13(2):990-1018. PubMed ID: 36686934
[TBL] [Abstract][Full Text] [Related]
5. Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia.
Saino Y; Kobayashi F; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1982 Oct; 22(4):564-70. PubMed ID: 6983856
[TBL] [Abstract][Full Text] [Related]
6. Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.
Then RL; Angehrn P
Antimicrob Agents Chemother; 1982 May; 21(5):711-7. PubMed ID: 6808912
[TBL] [Abstract][Full Text] [Related]
7. Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873.
Saino Y; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1984 Mar; 25(3):362-5. PubMed ID: 6609682
[TBL] [Abstract][Full Text] [Related]
8. Comparison of susceptibilities of anaerobic bacteria to cefmenoxime, ceftriaxone, and other antimicrobial compounds.
Pollock HM; Holt J; Murray C
Antimicrob Agents Chemother; 1983 May; 23(5):780-3. PubMed ID: 6307137
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of cefodizime (HR-221).
Ahonkhai VI; Cherubin CE; Shulman MA
Antimicrob Agents Chemother; 1982 Oct; 22(4):715-8. PubMed ID: 6295264
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility.
Ahonkhai VI; Cherubin CE; Shulman MA; Bancroft U
Antimicrob Agents Chemother; 1982 Jun; 21(6):999-1002. PubMed ID: 6287933
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity and beta-lactamase stability of cefmenoxime.
Neu HC; Labthavikul P
Antimicrob Agents Chemother; 1982 Aug; 22(2):316-22. PubMed ID: 6100427
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.
Imada A; Kondo M; Okonogi K; Yukishige K; Kuno M
Antimicrob Agents Chemother; 1985 May; 27(5):821-7. PubMed ID: 3874598
[TBL] [Abstract][Full Text] [Related]
13. Purification and properties of inducible penicillin beta-lactamase isolated from Alcaligenes faecalis.
Fujii T; Sato K; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1985 Apr; 27(4):608-11. PubMed ID: 3873902
[TBL] [Abstract][Full Text] [Related]
14. Beta-lactamase stability of cefpirome (HR 810), a new cephalosporin with a broad antimicrobial spectrum.
Kobayashi S; Arai S; Hayashi S; Fujimoto K
Antimicrob Agents Chemother; 1986 Nov; 30(5):713-8. PubMed ID: 3492175
[TBL] [Abstract][Full Text] [Related]
15. Purification and properties of a beta-lactamase produced by Branhamella catarrhalis.
Yokota E; Fujii T; Sato K; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1986 Apr; 29(4):696-8. PubMed ID: 3486631
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
Utsui Y; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
[TBL] [Abstract][Full Text] [Related]
17. Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Campoli-Richards DM; Todd PA
Drugs; 1987 Aug; 34(2):188-221. PubMed ID: 3304966
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical antibacterial activity of cefmenoxime against Proteus vulgaris.
Ikeda Y; Nishino T; Tanino T
Antimicrob Agents Chemother; 1987 Jun; 31(6):865-9. PubMed ID: 3304155
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical antibacterial activities of beta-lactams against Proteus vulgaris: mechanism of the paradoxical effect.
Ikeda Y; Nishino T
Antimicrob Agents Chemother; 1988 Jul; 32(7):1073-7. PubMed ID: 3056246
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of Rhodobacter sphaeroides to beta-lactam antibiotics: isolation and characterization of a periplasmic beta-lactamase (cephalosporinase).
Baumann M; Simon H; Schneider KH; Danneel HJ; Küster U; Giffhorn F
J Bacteriol; 1989 Jan; 171(1):308-13. PubMed ID: 2783689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
